Diagnostic Yield of Electroanatomic Voltage Mapping in Guiding Endomyocardial Biopsies
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: Electroanatomic voltage mapping (EVM) is a promising modality for guiding endomyocardial biopsies (EMBs). However, few data support its feasibility and safety. We now report the largest cohort of patients undergoing EVM-guided EMBs to show its diagnostic yield and to compare it with a cardiac magnetic resonance (CMR)–guided approach. Methods: We included 162 consecutive patients undergoing EMB at our institution from 2010 to 2019. EMB was performed in pathological areas identified at EVM and CMR. CMR and EVM sensitivity and specificity regarding the identification of pathological substrates of myocardium were evaluated according to EMB results. Results: Preoperative CMR showed late gadolinium enhancement in 70% of the patients, whereas EVM identified areas of low voltage in 61%. Right (73%), left (19%), or both ventricles (8%) underwent sampling. EVM proved to have sensitivity similar to CMR (74% versus 77%), with specificity being 70% and 47%, respectively. In 12 patients with EMB-proven cardiomyopathy, EVM identified pathological areas that had been undetected at CMR evaluation. Sensitivity of pooled EVM and CMR was as high as 95%. EMB analysis allowed us to reach a new diagnosis, different from the suspected clinical diagnosis, in 39% of patients. The complications rate was low, mostly related to vascular access, with no patients requiring urgent management. Conclusions: EVM proved to be a promising tool for targeted EMB because of its sensitivity and specificity for identification of myocardial pathological substrates. EVM was demonstrated to have accuracy similar to CMR. EVM and CMR together conferred a positive predictive value of 89% on EMB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Self-citationMyocarditis: The Dallas criteria
Thomas Aretz, H. (1987) · Human Pathology · doi:10.1016/s0046-8177(87)80363-5 · Cited by 809
Fung, G., Luo, H., Qiu, Y., Yang, D., & McManus, B. (2016) · Circulation Research · doi:10.1161/circresaha.115.306573 · Cited by 444
Corrado, D., van Tintelen, P. J., McKenna, W. J., Hauer, R. N. W., Anastastakis, A., Asimaki, A., Basso, C., Bauce, B., Brunckhorst, C., Bucciarelli-Ducci, C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz669 · Cited by 366
Self-citation
Cited by
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
Self-citation2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Self-citation2025 ESC Guidelines for the management of myocarditis and pericarditis
Schulz-Menger, J., Collini, V., Gröschel, J., Adler, Y., Brucato, A., Christian, V., Ferreira, V. M., Gandjbakhch, E., Heidecker, B., Kerneis, M., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf192 · Cited by 434
Self-citationDiagnosis and Treatment of Acute Myocarditis: A Review
Ammirati, E., & Moslehi, J. J. (2023) · JAMA · doi:10.1001/jama.2023.3371 · Cited by 379
Seferović, P. M., Tsutsui, H., McNamara, D. M., Ristić, A. D., Basso, C., Bozkurt, B., Cooper, L. T., Filippatos, G., Ide, T., Inomata, T., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2190 · Cited by 219
Self-citationAmmirati, E., Buono, A., Moroni, F., Gigli, L., Power, J. R., Ciabatti, M., Garascia, A., Adler, E. D., & Pieroni, M. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01680-x · Cited by 98
Tan, J. L., Tan, B. E.-X., Cheung, J. W., Ortman, M., & Lee, J. Z. (2023) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.04.007 · Cited by 34
Uccello, G., Bonacchi, G., Rossi, V. A., Montrasio, G., & Beltrami, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010150 · Cited by 33
“…acute HF or cardiogenic shock, such as in fulminant myocarditis cases, hemodynamic and mechanical circulatory support should be considered early [124]. systolic dysfunction occurs, guidelines-directed HF medical therapy is indicated, while in acute HF In myocarditis secondary to autoimmune or…”
BackgroundCOVID-19 and Myocarditis: Review of Clinical Presentations, Pathogenesis and Management
Lovell, J. P., Division of Cardiology, D. O. M., Čiháková, D., Department of Pathology, J. H. U. O. M., W. Harry Feinstone Department of Molecular Microbiology and Immunology, J. H. U. B. S. O. P. H., Gilotra, N. A., & Division of Cardiology, D. O. M. (2022) · Heart International · doi:10.17925/hi.2022.16.1.20 · Cited by 29
Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art
Campodonico, J., Lauri, C., Pezzuto, B., Agostoni, P., & Vignati, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217661 · Cited by 6
Daoud, A., Kalinoski, H., Talor, M. V., Welsh, R. A., Jo, W., Jaime, C. M., Kolim, B., Mahto, N., Kveton, M., Weislová, I., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf209 · Cited by 4
Metadata
- Authors
- Casella, M., Dello Russo, A., Bergonti, M., Catto, V., Conte, E., Sommariva, E., Gasperetti, A., Vettor, G., Tundo, F., Sicuso, R., Rizzo, S., Mushtaq, S., Della Rocca, D., Pompilio, G., Di Biase, L., Andreini, D., Natale, A., Basso, C., & Tondo, C.
- Venue
- Circulation
- Published
- 2020-09-29
- Volume
- 142
- Issue
- 13
- Pages
- 1249-1260
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3049342516
- Cited by
- 103
- References
- 4
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.